STOCK TITAN

My Quest Story – Martha Baer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Martha Baer shares her 31-year journey with Quest Diagnostics, starting in 1993 as a courier at Nichols Institute. Through various company transitions and acquisitions, including Corning Clinical Laboratories and Smith Kline Beecham Clinical Laboratories, she experienced significant professional growth. The acquisition of Smith Kline Beecham marked a major expansion, moving operations to a larger facility in Kansas City, MO. Baer progressed from courier to stock clerk, Group Lead, and eventually to her current role as Network Planner and Route Optimization Specialist for the Greater Midwest Region. Her career particularly advanced during the LabOne acquisition in Lenexa, KS, where she took on increased responsibilities.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-0.22% News Effect

On the day this news was published, DGX declined 0.22%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTHAMPTON, MA / ACCESSWIRE / October 23, 2024 / Quest Diagnostics

I have been with Quest Diagnostics since 1993, celebrating my 31 years with the company this past July. My entire career has been in Logistics. I began my career as a courier, working for what then was Nichols Institute. For the next several years, we experienced transitions to Corning Clinical Laboratories and ultimately to Quest Diagnostics.

The big change came when Quest Diagnostics bought Smith Kline Beecham Clinical Laboratories. We went from working out of a space about the size of a four-car garage to the much larger lab in Kansas City, MO. This acquisition allowed many opportunities for upward growth. My position changed from courier to stock clerk in their huge warehouse. I quickly moved up to become the Group Lead, working for Ken Johnson. My period of upward mobility with Quest Diagnostics had taken off.

After years of both personal and professional growth, Quest Diagnostics acquired LabOne clinical reference laboratories, which was in Lenexa, KS. The first few years in Lenexa were some of the most challenging and rewarding in my career. I had a great deal of responsibility before, during, and after our entire staff moved there. I became the route administrator for the region, logistics supervisor over Joplin and Springfield, MO, and ultimately transitioned to my current title of Network Planner and Route Optimization Specialist for the Greater Midwest Region.

My time with Quest Diagnostics has been quite remarkable. I have met people from all levels of society, traveled places I thought I would never see, made many close friendships, and learned so much about leadership, collaboration, and teamwork. I have enjoyed some of the best years of my life working for Quest Diagnostics. I would not change these past 31 years with the company for anything.

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics



View the original press release on accesswire.com

FAQ

When did Martha Baer join Quest Diagnostics (DGX)?

Martha Baer joined Quest Diagnostics (then Nichols Institute) in 1993, marking a 31-year career with the company as of 2024.

What major acquisition by Quest Diagnostics (DGX) impacted Martha Baer's career growth?

The acquisition of Smith Kline Beecham Clinical Laboratories was a significant milestone that led to expansion into a larger facility in Kansas City, MO, creating opportunities for Baer's career advancement.

What is Martha Baer's current position at Quest Diagnostics (DGX)?

Martha Baer currently serves as Network Planner and Route Optimization Specialist for the Greater Midwest Region at Quest Diagnostics.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

19.60B
110.75M
0.4%
99.16%
3.8%
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS